The way we communicate and interact digitally is constantly changing. Unfortunately, fraud and scams are the order of the day ...

Summit’s PD-1 bispecific antibody outperformed MSD’s Keytruda in a Phase III trial enrolling patients with lung cancer.

With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...

QuEra Computing Inc. has started a collaboration with Deloitte Tohmatsu Group intended to advance the quantum industry in ...

Biometric Derived Keys introduced by Tech5 enable encrypted sharing of identity data through selective disclosure while ...

Generation Bio is a biotechnology company changing what's possible for people living with T cell-driven autoimmune diseases. The company is developing a new modality of therapeutics leveraging its T ...

Webcasts of the fireside chats will be available under the Events and Presentations section of the Company’s investor relations website at https://cullinantherapeutics.com/events-and-presentations/.

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

Discover how Peloton overcame overexpansion challenges with strategic restructuring, boosting FY 2025 EBITDA guidance and ...

Mims Davies MP's weekly column on becoming a Patron for the Greenaway Foundation, Westminster after Recess, joining Ashurst ...

Strong evidence for ALS often comes from familial forms of the disease, where specific gene mutations— for example in the ...

AUGUSTA TOWNSHIP, MI - Laura Angel has long known she wanted to teach. Her mother was an art teacher, and she followed in her footsteps. Angel has spent about 16 years out of her 18-year teaching ...